Depression affects many people, but antidepressant treatment does not work equally well for everyone. Predicting treatment outcomes early could help clinicians make more informed decisions and tailor treatment to individual patients.
In this postdoc project, you will investigate how adaptive, AI-informed mid-field MRI, guided by questionnaire data, can provide clinically useful biomarkers for predicting antidepressant treatment outcomes. By combining artificial intelligence, brain imaging and digital mood and symptom data, you will work towards a more affordable and widely accessible approach to precision psychiatry.
You will focus on three main areas:
You will build on data from a large randomized clinical trial on treatment outcomes in major depressive disorder. Using these data, you will adapt existing prediction models and investigate whether mid-field perfusion MRI can support the early prediction of antidepressant treatment outcomes.
You will develop an end-to-end prediction pipeline and translate your methods into an adaptive MRI strategy that can run directly on the scanner. You will also design and conduct a pilot MRI study in healthy volunteers, testing a prototype model deployed on the scanner.
In addition, you will share your findings with the scientific community and contribute to the further development of the PRESS platform in collaboration with consortium partners from academia and industry. Your responsibilities include:
You have a PhD in artificial intelligence, computer science, (biomedical) engineering, physics, computational neuroscience, technical medicine or a closely related field. You enjoy developing new technical approaches and applying them to clinically relevant challenges.
In addition, you bring:
Watch this video with more information about joining Amsterdam UMC Research BV.
You will work at Amsterdam UMC in a multidisciplinary research environment involving the departments of Radiology and Biomedical Engineering & Physics. You will collaborate with clinical experts, imaging physics scientists and AI researchers to develop innovative MRI methods and translate them into meaningful outcomes for patients with depression.
You will also work closely with industry partners in the PRESS consortium. These partners develop the digital platform and mid-field MRI enhancement technology that support the implementation of your methods. Together, you will explore how adaptive MRI and AI can contribute to more accessible healthcare, including in community-based and resource-limited settings.
This position offers the opportunity to bring AI research from technical development to practical application in precision psychiatry. You will work at the interface of engineering, clinical research and industry, contributing to methods that could help make personalized depression treatment more widely accessible.
Amsterdam UMC Research BV
Amsterdam UMC Research BV supports non-profit scientific research. In doing so, we provide researchers with everything they need to excel. Our principal investigators (PIs) and project leaders offer support in the field of project management, finance and human resources. In medical scientific research projects, legal support is also provided.
Watch the video to find out more.
The first round of interviews is expected to take place during the first two weeks of December. Please keep this in mind when planning your availability. The second round will follow shortly after the first.
During the publication period, applications will be handled continuously. If the vacancy is filled, it will be closed prematurely.
Do you have any questions? For further information about this position, please contact Prof. Liesbeth Reneman, at l.reneman@amsterdamumc.nl or Matthan Caan, PhD, at m.w.a.caan@amsterdamumc.nl.
A reference check, screening and hiring assessment may be part of the procedure. Read here whether that applies to you. If you join us, we ask you for a VOG (Certificate of Good Conduct).
Internal candidates will be given priority over external candidates in case of equal suitability.
Acquisition in response to this vacancy will not be considered.


